TABLE 2.
No Prevalent Fractures | Prevalent Fractures | ||
---|---|---|---|
N (%)Mean ± SD | N (%)Mean ± SD | p-value | |
Overall cohort | 871 (100%) | 131 (100%) | . |
Age | 78.6 ± 0.17 | 78.72 ± 0.43 | 0.853 |
Residence | 0.171 | ||
Mexico | 125 (14.35) | 13 (9.92) | . |
USA | 746 (85.65) | 118 (90.08) | . |
Race | 0.035 | ||
White | 635 (72.90) | 109 (83.21) | . |
Other | 236 (27.10) | 22 (16.79) | . |
BMI | 28.15 ± 0.14 | 28.09 ± 0.40 | 0.732 |
ADT duration | 0.647 | ||
<= 1 year | 136 (16.23) | 18 (14.40) | . |
> 1 year | 702 (83.77) | 107 (85.60) | . |
ADT | 0.412 | ||
GnRH agonist | 801 (91.96) | 120 (91.60) | . |
bilateral orchiectomies | 70 (8.04) | 11 (8.40) | . |
Testosterone | 31.61 ± 2.44 | 23.47 ± 0.76 | 0.274 |
Estradiol | 12.17 ± 0.28 | 11.25 ± 0.65 | 0.185 |
Estradiol | 0.096 | ||
<= median | 430 (51.37) | 76 (58.46) | . |
> median | 407 (48.63) | 54 (41.54) | . |
CTX | 0.59 ± 0.01 | 0.59 ± 0.02 | 0.997 |
BSAP | 28.93 ± 0.45 | 29.43 ± 0.82 | 0.537 |
Osteocalcin | 11.47 ± 0.20 | 11.77 ± 0.43 | 0.640 |